German pharmaceutical company Stada plans a multi-billion-euro IPO in Frankfurt this autumn to reduce debt and provide an exit for its private equity owners.
UK power producer Drax Group under FCA investigation for biomass sourcing and reporting compliance, but analysts remain positive on the company's outlook.
German pharmaceutical company Stada plans a multi-billion-euro IPO in Frankfurt this autumn to reduce debt and provide an exit for its private equity owners.
UK power producer Drax Group under FCA investigation for biomass sourcing and reporting compliance, but analysts remain positive on the company's outlook.